Director at Marsh & McLennan (MMC) credited dividend-based restricted stock units

Rhea-AI Filing Summary

Marsh & McLennan Companies director Tamara Ingram reported an automatic increase in equity-based compensation. She received 39.82 restricted stock units as dividend equivalents under the company’s Directors Stock Compensation Plan, each convertible into one share of common stock, bringing her directly held restricted stock units to 7,693.42.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ingram Tamara

(Last) (First) (Middle)

C/O MARSH & MCLENNAN COMPANIES, INC.

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MRSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stk. Units-Dir. Stk. Plan	(1)	02/13/2026		J(2)	V	39.82		(3)	(3)	Common Stock	39.82	$172.98	7,693.42	D

Explanation of Responses:

1. The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.

2. Acquired with dividend equivalents credited to the reporting person's account under the Marsh & McLennan Companies Directors Stock Compensation Plan.

3. Not Applicable

	/s/ Tessa Patti, Attorney-in-fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Marsh & McLennan (MMC) director Tamara Ingram report on this Form 4?

Tamara Ingram reported an automatic equity adjustment, receiving 39.82 restricted stock units. These units were credited as dividend equivalents under the Marsh & McLennan Companies Directors Stock Compensation Plan and are a routine form of non-cash director compensation tied to common stock.

How many restricted stock units does Tamara Ingram hold after this MMC transaction?

After this transaction, Tamara Ingram holds 7,693.42 restricted stock units directly. This total reflects the additional 39.82 units credited as dividend equivalents on existing holdings under the company’s Directors Stock Compensation Plan, as disclosed in the Form 4 filing.

At what reference price were Tamara Ingram’s new restricted stock units recorded for MMC?

The 39.82 additional restricted stock units were recorded at a reference price of $172.98 per unit. This price is used for reporting purposes and reflects the value applied when crediting dividend equivalents under the Directors Stock Compensation Plan.

Do Tamara Ingram’s restricted stock units at MMC convert into common stock?

Yes, each restricted stock unit converts into Marsh & McLennan Companies common stock on a one-for-one basis. This means the 7,693.42 units reported represent the right to receive an equal number of MMC common shares, subject to the plan’s terms and conditions.

Was this MMC Form 4 transaction a market buy or sell by Tamara Ingram?

No, the Form 4 identifies the transaction with code “J,” described as an “other acquisition or disposition.” The footnotes explain the 39.82 units were acquired as dividend equivalents under a director stock compensation plan, not through an open-market purchase or sale.